Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.11 USD | +1.26% | +8.41% | -11.43% |
05-07 | Beam Therapeutics Shares Fall After Q1 Revenue Misses Estimates | MT |
05-07 | Beam Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.43% | 1.9B | |
+29.77% | 49.46B | |
+1.00% | 42.58B | |
+49.62% | 42.49B | |
-5.26% | 29.09B | |
+13.68% | 26.61B | |
-22.99% | 18.64B | |
+8.22% | 13.16B | |
+32.41% | 12.55B | |
+24.01% | 12.1B |
- Stock Market
- Equities
- BEAM Stock
- News Beam Therapeutics Inc.
- Cantor Fitzgerald Lowers Price Target on Beam Therapeutics to $32 From $56, Maintains Overweight Rating